Human Rabies Vaccine IP

Human Rabies Vaccine IP Specification

Origin of Medicine
India

Drug Type
General Medicines

Physical Form
Capsules

Recommended For
Adults

Dosage Guidelines
As directed by a physician

Suitable For
Adults

Storage Instructions
Cool Dry and Dark Place

Human Rabies Vaccine IP Trade Information

Minimum Order Quantity
100 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

About Human Rabies Vaccine IP

Rabies vaccine is an inactivated vaccine that is used to prevent rabies in humans. The rabies vaccine is manufactured in two forms: inactivated (killed) vaccine and attenuated (weakened) vaccine. In India, the inactivated vaccine (IP) is used to prevent and treat rabies in humans. The inactivated vaccine contains a killed virus that is not able to cause infection but which stimulates the body to produce antibodies against the rabies virus. The inactivated vaccine is administered as an intramuscular injection in the deltoid muscle of the arm. The vaccine is usually given in three doses, with the second dose being given seven days after the first, and the third dose being given 21 days after the first. The vaccine should be given in the upper arm and not in the buttocks. Booster doses may be necessary if the person has been exposed to rabies or is at high risk of exposure.

Comprehensive Rabies Protection

The Human Rabies Vaccine IP offers reliable protection against rabies for adults at risk of exposure or after potential contact with the virus. As a general medicine, this vaccine is quality-assured and conveniently distributed in capsule form. With the support of qualified medical professionals, it creates a vital line of defense in communities, hospitals, and clinics. Trust in Indian pharmaceutical excellence for global health security.

Guidance for Safe Storage and Handling

This vaccine requires careful storage to maintain its effectiveness. Keep it in a cool, dry, and dark environment, away from moisture and direct sunlight. Following appropriate storage protocols ensures the vaccine remains potent and safe for use. Distributors, exporters, and wholesalers are advised to follow these guidelines diligently to preserve product quality during transit and storage.

FAQs of Human Rabies Vaccine IP:

Q: How is the Human Rabies Vaccine IP administered?

A: The Human Rabies Vaccine IP is administered as capsules, strictly following the dosage instructions provided by a physician. Self-medication should be avoided, and the vaccine should only be taken under medical supervision.

Q: What are the recommended storage conditions for this vaccine?

A: This vaccine should be stored in a cool, dry, and dark place. Avoid exposure to heat, light, or moisture, as these conditions may compromise the effectiveness of the capsules.

Q: When should the vaccine be used?

A: The vaccine is recommended for adults who may be at risk of rabies exposure or have potentially been exposed to the virus. Immediate consultation with a healthcare provider after potential exposure is essential.

Q: Where is this vaccine available for purchase?

A: The Human Rabies Vaccine IP is distributed, exported, supplied, and wholesaled throughout India by authorized distributors, exporters, suppliers, and wholesalers.

Q: What are the benefits of using the Human Rabies Vaccine IP?

A: This vaccine helps prevent rabies infection, offering vital protection to adults at risk. It is part of an effective immunization strategy endorsed by healthcare professionals.

Q: What is the process for receiving this vaccine?

A: Consult a healthcare provider for assessment and prescription. The vaccine is administered under medical supervision, with the dosage and schedule tailored to individual needs.

Q: How does the vaccine work to protect against rabies?

A: The vaccine stimulates the bodys immune system to produce antibodies, providing protection if exposed to the rabies virus. This helps prevent the onset of rabies when administered promptly after possible exposure.